Honz Pharmaceutical Co., Ltd. announced a private placement to issue not more than 80,000,000 shares for gross proceeds of not more than CNY 297,240,500 on June 30, 2022. The issue price is not less than 80% of the average price in the 20 trading days before the pricing reference date. The transaction will include not more than 35 investors.

The shares cannot be transferred within 6 months from the issuance closing date. The transaction has been approved by the shareholders at the annual general shareholders meeting of 2021. The transaction is subject to the approvals of the Shenzhen Stock Exchange and the China Securities Regulatory Commission.